Combination of daptomycin plus ceftriaxone is more active than vancomycin plus ceftriaxone in experimental meningitis after addition of dexamethasone
- PMID: 19364870
- PMCID: PMC2704679
- DOI: 10.1128/AAC.00952-08
Combination of daptomycin plus ceftriaxone is more active than vancomycin plus ceftriaxone in experimental meningitis after addition of dexamethasone
Abstract
We examined the cerebrospinal fluid penetration of daptomycin after the addition of dexamethasone and its bactericidal efficacy with and without ceftriaxone in an experimental rabbit model of pneumococcal meningitis. The combination of daptomycin with ceftriaxone was the most efficacious regimen for pneumococcal meningitis. The previous addition of dexamethasone affected the antibacterial activity of daptomycin only marginally, either as monotherapy or combined with ceftriaxone, although the penetration of daptomycin into inflamed meninges was significantly reduced from 6 to 2%. Daptomycin with ceftriaxone might be a potential candidate for the empirical therapy of bacterial meningitis, although the activity of this regimen against Listeria monocytogenes remains to be demonstrated.
Figures




Similar articles
-
Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis.J Antimicrob Chemother. 2006 Apr;57(4):720-3. doi: 10.1093/jac/dkl007. Epub 2006 Feb 3. J Antimicrob Chemother. 2006. PMID: 16459345
-
Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis.Antimicrob Agents Chemother. 1995 Sep;39(9):2158-60. doi: 10.1128/AAC.39.9.2158. Antimicrob Agents Chemother. 1995. PMID: 8540738 Free PMC article.
-
Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis.Antimicrob Agents Chemother. 2004 Oct;48(10):3928-33. doi: 10.1128/AAC.48.10.3928-3933.2004. Antimicrob Agents Chemother. 2004. PMID: 15388454 Free PMC article.
-
Bacterial meningitis: an update of new treatment options.Expert Rev Anti Infect Ther. 2015;13(11):1401-23. doi: 10.1586/14787210.2015.1077700. Epub 2015 Aug 18. Expert Rev Anti Infect Ther. 2015. PMID: 26293166 Review.
-
Streptococcus agalactiae Meningitis in an Immunocompetent Adult: A Case Report and Literature Review.Intern Med. 2024 May 1;63(9):1301-1303. doi: 10.2169/internalmedicine.2279-23. Epub 2023 Sep 29. Intern Med. 2024. PMID: 37779069 Free PMC article. Review.
Cited by
-
Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis.Antimicrob Agents Chemother. 2012 Aug;56(8):4289-95. doi: 10.1128/AAC.00674-12. Epub 2012 May 29. Antimicrob Agents Chemother. 2012. PMID: 22644021 Free PMC article.
-
Attenuation of cerebrospinal fluid inflammation by the nonbacteriolytic antibiotic daptomycin versus that by ceftriaxone in experimental pneumococcal meningitis.Antimicrob Agents Chemother. 2010 Mar;54(3):1323-6. doi: 10.1128/AAC.00812-09. Epub 2010 Jan 11. Antimicrob Agents Chemother. 2010. PMID: 20065062 Free PMC article.
-
Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia.Diagn Microbiol Infect Dis. 2011 Nov;71(3):286-90. doi: 10.1016/j.diagmicrobio.2011.07.001. Epub 2011 Aug 19. Diagn Microbiol Infect Dis. 2011. PMID: 21855248 Free PMC article.
-
Pharmacokinetics of single-dose daptomycin in patients with suspected or confirmed neurological infections.Antimicrob Agents Chemother. 2011 Jul;55(7):3505-9. doi: 10.1128/AAC.01741-10. Epub 2011 Apr 18. Antimicrob Agents Chemother. 2011. PMID: 21502620 Free PMC article.
-
Pathogenesis and pathophysiology of pneumococcal meningitis.Clin Microbiol Rev. 2011 Jul;24(3):557-91. doi: 10.1128/CMR.00008-11. Clin Microbiol Rev. 2011. PMID: 21734248 Free PMC article. Review.
References
-
- Aronin, S. I., P. Peduzzi, and V. J. Quagliarello. 1998. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann. Intern. Med. 129:862-869. - PubMed
-
- Cottagnoud, P. 2008. Daptomycin: a new treatment for insidious infections due to gram-positive pathogens. Swiss Med. Wkly. 138:93-99. - PubMed
-
- Cottagnoud, P., M. Pfister, F. Acosta, M. Cottagnoud, L. Flatz, F. Kuhn, H. P. Muller, and A. Stucki. 2004. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis. Antimicrob. Agents Chemother. 48:3928-3933. - PMC - PubMed
-
- Doern, G. V., M. A. Pfaller, K. Kugler, J. Freeman, and R. N. Jones. 1998. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin. Infect. Dis. 27:764-770. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical